Compare ARK Genomic Revolution ETF (ARKG) vs VanEck Junior Gold Miners (GDXJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs VanEck Junior Gold Miners — how do they compare? ARK Genomic Revolution ETF trades at $40.73, while VanEck Junior Gold Miners trades at $96.25. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, VanEck Junior Gold Miners nearer its low. Which is the better fit depends on your goals.
| ARKG | GDXJ | |
|---|---|---|
Sector | Sector/Thematic | Commodities - Metals/Agriculture |
52-Week High | $43.57 | $156.19 |
52-Week Low | $23.09 | $64.22 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
GDXJ trades at $98.91, down 0.06% on the day, with a bearish technical outlook as moving averages signal selling pressure and key support lies at $97. The ETF has underperformed peers in 2026, with Seeking Alpha noting double-digit declines amid concerns over its small-cap exposure and portfolio overlap. Recent news highlights investor caution toward junior gold miners compared to senior counterparts.
The investment case remains challenged by weak sentiment and technical headwinds, though potential exists as a hedge during market corrections. Risks include Federal Reserve policy impacts on gold prices and competition from other mining ETFs. Wall Street sentiment is cautious, with no bullish analyst signals evident in recent data.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About VanEck Junior Gold Miners
GDXJ provides exposure to small and mid-cap companies in the global gold and silver mining industry. It focuses on 'junior' miners involved in exploration and early production, featuring 2026 leaders like Pan American Silver and Coeur Mining.
Read more on GDXJ →
